Shopping Cart
- Remove All
- Your shopping cart is currently empty
GnRH-R antagonist 1 (Compound 21a), is an orally active, membrane-permeable agent with a high binding affinity (IC50=0.57 nM) and potent in vitro antagonistic efficacy (IC50=2.18 nM). It is utilized in research focused on advanced prostate cancer and the prevention of premature LH surges [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,420 | 10-14 weeks | |
50 mg | $3,180 | 10-14 weeks | |
100 mg | $4,300 | 10-14 weeks |
Description | GnRH-R antagonist 1 (Compound 21a), is an orally active, membrane-permeable agent with a high binding affinity (IC50=0.57 nM) and potent in vitro antagonistic efficacy (IC50=2.18 nM). It is utilized in research focused on advanced prostate cancer and the prevention of premature LH surges [1]. |
In vitro | GnRH-R antagonist 1 demonstrates a cell permeability that is 140 times greater than that of Relugolix, while also showing favorable stability in both human and mouse microsomes [1]. |
In vivo | GnRH-R antagonist 1 administered orally at a dosage of 30 mg/kg once daily for seven days exhibits a good safety profile [1]. At a single oral dose of 12 mg/kg, it demonstrates favorable pharmacokinetics and high oral bioavailability, evident from a 44.7% F% value [1]. Furthermore, this dosage effectively suppresses circulating testosterone levels in rats for over 24 hours [1]. |
Molecular Weight | 721.65 |
Formula | C31H28F5N7O6S |
Cas No. | 2826273-90-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.